Aims: To investigate the effectiveness of cardiogoniometry, a novel, non-invasive method, in diagnosing coronary artery disease (CAD) in women and compare it with exercise-ECG test, by using coronary angiography as a reference method. Methods: It was a single-centre, case-series study including consecutive female patients with stable angina pectoris (AP) undergoing coronary angiography. Exercise-ECG test, done according to the Bruce protocol, and cardiogoniometry were obtained prior to coronary angiography. Clinically significant CAD has been defined as one or more coronary lesions with >70% stenosis. Results: Study included 114 consecutive female patients with median age of 64.0 (58.0-71.0) years, out of which 32 (28.1%) had CAD. Cardiogoniometry yielded a total accuracy of 74.6% with a sensitivity of 75.0% (95% CI 56.6-88.5) and specificity of 74.4% (95% CI 63.6-83.4). Exercise-ECG test yielded a total accuracy of 45.1% with a sensitivity of 68.1% (95% CI 42.7-83.6) and specificity 36.6% (95% CI 25.2-50.3). Cardiogoniometry showed higher accuracy than exercise-ECG test (P < 0.001). Pathological cardiogoniometry was associated with almost nine times higher risk for CAD (OR 8.7,, P < 0.001), which remained significant after adjustment for age, and hypokinesia. Conclusion: Cardiogoniometry is a non-invasive, easy-to-use and free-of-risk method which showed high effectiveness in diagnosing stable CAD in women and superior to exercise-ECG test. Cardiogoniometry could be introduced as a part of the diagnostic algorithm of screening women for stable CAD and is suitable for use in the primary setting, especially in women unable to undergo stress-testing.
Introduction
Cardiovascular diseases, including coronary artery disease (CAD), are the main cause of death both worldwide and in Croatia. 1, 2 In 2012, they resulted in 17.5 million deaths worldwide, and in Europe they account over 4 million deaths per year, that is for 47% of all deaths and 52% deaths in women with somewhat less than half caused by CAD. Exercise-ECG test is the most available method in noninvasive CAD diagnostics with sensitivity of 70-77% and specificity of 65-80% in general population. However, in women the sensitivity of exercise-ECG test is only 60% (54-68%) and its specificity is 70% (64-75%). 3, 4 In meta-analyses including patients with or without previous myocardial infarction, exercise-ECG test has shown a predictive accuracy of 69-73% (sensitivity of 67-68%; specificity of 72-77%) for CAD diagnosis. 4, 5 However, exercise-ECG tests are often not meaningful due to limited stress capacity of the patient or are even contraindicated. 3, 5, 6 As a result of previously mentioned facts and the fact that patients should have at least moderate physical functioning with an interpretable ECG, which is rarely the case, over the last 20 years new non-invasive diagnostic methods have been developed and used. Twenty-four hour Holter-ECG registers ST-segment changes and arrhythmias, which are often the result of a CAD, but with low sensitivity. 3, 6 Stress-echocardiography, myocardial perfusion scintigraphy, single-photon emission computed tomography (SPECT) and cardiac magnetic resonance imaging (MRI) (with or without exercise or pharmacologic stress agents) are non-invasive methods which have shown to have greater efficiency than exercise-ECG test with sensitivity and specificity of 75-90%, bearing in mind that cardiac MRI is the most efficient of the mentioned. [6] [7] [8] Cardiogoniometry (CGM) is a non-invasive diagnostic method for CAD based on vectorial and digital analysis of myocardial depolarisation and repolarisation, providing projections of heart segments which are in relative or absolute ischemia at rest. 9 Previous research, which used coronary angiography as a reference method, has shown that the sensitivity of CGM for diagnosing CAD in general population amounts to 65-80% and its specificity to 70-85%. [9] [10] [11] When compared with standard ECG, CGM has shown to be more efficient (sensitivity 64-75% vs. 24-63%, specificity 82-90% vs. 70-81%), regardless of the used reference method (coronary angiography, cardiac MRI or SPECT). [10] [11] [12] [13] Furthermore, during emergency room observation of patients with chest pain, CGM has shown a higher level of sensitivity (69%) in diagnosing non ST elevation acute coronary syndrome than ECG and cardiac troponin I. 14 Considering the fact that exercise-ECG test is not sufficiently effective in diagnosing CAD, especially in women, and that other non-invasive methods carry certain risks including allergic reactions, kidney failure, stress related complications as well as X-ray radiation exposure, we sought to investigate the effectiveness of cardiogoniometry in diagnosing CAD in women and compare it with exercise-ECG test by using coronary angiography as a reference method.
Methods
This was a single-centre, case-series study including blinded evaluation of end-points. Between April 2014 and May 2015, 292 female patients with stabile AP were admitted to the Department of Cardiology, Sisters of Charity University Hospital Centre, Zagreb and we prospectively studied those who underwent coronary angiography. In this CGM@WAPE (CardioGonioMetry in Women's Angina Pectoris Evaluation) study, the female patients with the following features were eligible for inclusion: aged 18-85 without AP symptoms at rest and ECG without signs of ischemia, and normal cardioselective enzymes. The patients excluded from the study had the following: AP symptoms at rest or in minimal exercise, known CAD, anamnesis of acute coronary syndrome, left bundle branch block, permanent cardiac pacemaker or implantable cardioverterdefibrillator, underwent cardiothoracic surgery, congenital heart disease (surgically corrected or not), moderate or high degree valvular disease, chronic renal failure !grade III, chronic obstructive pulmonary disease, life-expectancy of less than 1 year, anaemia (haemoglobin <100 g/l), anamnesis of alcohol and/or drug addiction, urgent clinical state during hospitalization, pregnant women or participated in another clinical trial (Fig. 1 ).
Study protocol
All female patients were admitted to the Department of Cardiology because they showed symptoms of stable AP, and they underwent exercise-ECG test which was pathological or inconclusive or did not do exercise-ECG test due to physical incompetence, and consequently had indication for elective coronary angiography issued by one of the hospital's interventional cardiologists. Exercise-ECG test was done using treadmill exercise and according to the international accepted protocol of Bruce. 15 An interventional cardiologist who performed the coronary angiography was blinded to the results of the CGM, but knew the results of exercise-ECG test. All CGMs were obtained by one investigator who was blinded to all patient data and prior to coronary angiography. Thus, the study included blinded evaluation of end-points which included effectiveness of cardiogoniometry as well as one of the exercise-ECG test. Effectivenesses were evaluated according to the results of coronary angiography (invasive and thus reference method) and the corresponding results were compared. Upon admission all patients were evaluated for demographic data, co-morbidities and risk factors, and clinical examination as well as 12-lead ECG were carried out. Standard laboratory tests including complete blood count, creatinekinase, aspartate-aminotransferase, cardiac troponin T, lipidogram and C-reactive protein were obtained on admission. Echocardiography was performed using the standard protocol with emphasis on systolic and diastolic function of left ventricle, left ventricular wall thickness and the left ventricular ejection fraction (LVEF), which was calculated using the method by Teicholz. 16 Before performing cardiogoniometry and coronary angiography, signed informed consent for participation in the study was obtained from all enrolled patients. The Hospital Ethics Committee gave its ethical approval of the study, which was conducted according to the Declaration of Helsinki. The study was registered in DRKS registry (Deutschen Registers KlinischerStudien, ID: DRKS00006119) since April 2014 as a prospective clinical trial with universal trial number U1111-1149-9099.
Cardiogoniometry
Contemporary cardiogoniometry is a spatio-temporal, orthogonal-lead method using five electrodes and a computedautomated algorithm to analyse a 12-s vectorcardiographic recording in the resting patient. The CGM measurements were obtained by using commercial CGM device (Cardiologic Explorer, Enverdis GmbH, Jena, Germany) equipped with adequate software. During CGM recording, patients laid in a supine position and after a normal expiration, were asked to hold their breath for 12-15 s to minimize thoracic excursion during measurement. If it was not possible, they were asked to perform shallow breathing and keep their thoracic excursions to a minimum. The principles of the CGM have been published in detail previously. [9] [10] [11] [12] [13] Briefly, four electrodes were placed perpendicular at four points on the patients' thorax: point 1, in the fifth intercostals space on mid-clavicle line (point V4 of Wilson); point 2 at a point opposite to electrode 1 on back (point V8 of Wilson); point 3 located perpendicularly above electrode 1 at 0.7 times the distance between point 1 and 2; and point 4 placed horizontally to the right of point 3 at the same distance between points 1 and 3; fifth electrode was pointed on the right costal arch as grounding. These four electrodes define two planes perpendicular to each other with vectorial addition of the potentials measured between three electrodes in each plane and yield a vector corresponding to the projection of the heart vector into this plane. Using the vector projections in the two orthogonal planes, the heart vector can be reconstructed for every millisecond. [9] [10] [11] Cardiogoniometry provided an automatic dichotomous result, either normal (score 0) or abnormal (score <0) (Fig. 2) . When all parameters are within normal range, a score of zero is produced which means the CGM is 'negative'. If any parameter is out of range, the score is below zero, thus defining a pathological or 'positive' CGM. The numerical value of the score below zero does not reflect a measure of extent or severity of ischemia.
Coronary angiography
Most coronary angiographies were performed using a transradial approach. The Allen's clinical test was performed in all patients and when the phenomenon was considered abnormal the femoral approach was used. Before the procedure started, all patients received 100 mg of acetyl-salicylic acid and 300 mg of clopidogrel orally. A total of 200 lg verapamil (to prevent arterial vasospasm) and 3000-5000 IU of heparin were given after arterial sheath placement. Diagnostic angiography was performed using 5 Fr multipurpose catheters and coronary intervention by using variety of 6 or 7 Fr guiding catheters. 17 Clinically significant CAD has been defined as one or more lesions with >70% stenosis.
Statistical analysis
Baseline characteristics of the study population were presented as median with interquartile range. Continuous variables were compared with nonparametric Mann-Whitney test and categorical variables were compared with Fisher's exact test. Logistic regression was used to analyse the association between all variables of interest and the presence of CAD. Multivariate logistic regression was used to adjust for confounding factors. Sensitivity and specificity were calculated for CGM and exercise-ECG test. Power analysis for logistic regression demonstrated a power of 88%, when assuming uniform data distribution. P values < 0.05 were considered significant. The statistical analysis was done using SPSS Version 20 (IBM SPSS Statistics, New York, USA).
Results
Out of a total of 292 consecutive female patients with stable AP admitted to the Department of Cardiology, Sisters of Charity University Hospital Centre, Zagreb during the study period, 116 patients met the inclusion/exclusion criteria. Two patients refused to participate in the study, and consequently the final number of patients included in the study was 114 consecutive female patients with median age of 64.0 (58.0-71.0) years (minimum 37 and maximum 81 years) (Fig. 1) . Cardiogoniometry was done 24 h before coronary angiography. There were none adverse events related to cardiogoniometry, and there were no serious adverse events requiring hospitalization prolongation due to coronary angiography. A total of 32 patients (28.1%) had CAD, including one-vessel disease in 20 patients (62.5%) and double or triple vessel disease in 12 patients (37.5%) out of which 4 with left main coronary artery stenosis. In total 107 patients were in sinus rhythm and 7 had atrial fibrillation at the time of the study, out of which 3 patients with and 4 without CAD (P ¼ 0.096). A total of 28 patients with and 14 without CAD showed non-specific predefined ST-segment/T-wave changes in resting 12-lead ECG (P ¼ 0.576) and 3 patients with vs one without the CAD had right bundle branch block (P ¼ 0.714), however without statistical significance between the groups. The differences between the patients with and without the CAD are presented in Table 1 .
Patients with CAD were older and had similar anthropometric characteristics and laboratory findings as patients without CAD. Exercise-ECG test yielded a total accuracy of 45.1%, with a sensitivity of 68.1% (95% CI 42.7-83.6) and specificity 36.7% (95% CI 25.2-50.3), as well as positive predictive value (PPV) 28.3% (95% CI 16.8-42.3) and negative predictive value (NPV) 75.86% (95% CI 56.5-89.7).
The CGM score was normal in 69 patients (60.5%) and pathological in 45 patients (39.5%) with median of À1 (À2 to 0). CGM results were statistically significantly different between the two groups. CGM was positive in 75% of patients with CAD, unlike 25% of patients without CAD (P < 0.001). CGM yielded a total accuracy of 74.6% with a sensitivity of 75.0% (95% CI 56.6-88.5), a specificity of 74.4% (95% CI 63.6-83.4), as well as a PPV of 53.3% (95% CI 37.9%-68.3), and a NPV of 88.4% (95% CI 78.4-94.8).
CGM was more accurate in comparison with exercise-ECG test (74.6% vs 45.1%, P < 0.001). The CGM outcome did not correlate with the number of abnormal coronary arteries.
In a univariate model, positive CGM was associated with almost nine times higher risk for CAD (OR 8.7, 95%CI 3.4-22.3, P < 0.001). Out of echocardiography parameters only hypokinesia had positive association with CAD (OR 5.08, 95%CI 1.12-23.10, P ¼ 0.035) and diastolic dysfunction was not associated with CAD (OR 2.34, 95% CI 0.61-8.93, P ¼ 0.213). However, the association between CGM and CAD remained significant after adjustment for age and hypokinesia (OR 3.7, 95% CI 1.2-11.3, P ¼ 0.021).
Discussion
Non-invasive detection of CAD has been done by using exercise-ECG test for a long period of time, and it is still done. However, exercise-ECG test is not very suitable for detecting stable CAD due to certain limitations: it is insufficiently sensitive, especially in women, and there are problems regarding stress testing for ageing and increasingly overweight population, which shows the large incidence of chronic locomotor and back pain syndromes with or without autoimmune aetiology (especially frequent in women) resulting in impossibility for many women to achieve adequate levels of stress. [18] [19] [20] Our research has shown high effectiveness of CGM in diagnosing CAD in women with total accuracy of 74.6% (sensitivity 75.0%, specificity 74.4%) and NPV of 88.4% referring to coronary angiography as a reference method. Similar results were shown in previous research done for general population, which compared CGM with ECG by using as reference methods other non-invasive methods (such as cardiac MRI) or coronary angiography. [10] [11] [12] [13] [14] 20, 21 We have compared CGM with exercise-ECG test, which is much more effective than ECG in diagnosing stable CAD and although exercise-ECG test is a method which uses stress, CGM proved to be more accurate (74.6 vs. 45.1%, P < 0.001). Our research has shown lower specificity (36.8%) of exercise-ECG test and thus accuracy when compared with previous research, with sensitivity falling within the expected range. 4, 5, 18 Moreover, the CAD prevalence was lower in study population than it could be expected considering the CAD prevalence in women and the fact that the study was carried out in a tertiary centre. The cause of lower sensitivity could be explained by higher number of cardiologists who issued indication for coronary angiography. Moreover, the cause of lower CAD prevalence in study population could be explained by lower exercise-ECG test specificity, high percentage of exercise-ECG tests which were inconclusive (35%) as well as by the fact that some indications for coronary angiography were based only on the clinical AP symptoms because almost 30% of patients could not undergo exercise-ECG test and other forms of non-invasive diagnostic methods are not widely available in Croatia due to a lack of financial resources. In line with previous research, exercise-ECG test and CGM had better sensitivity in detecting CAD in elderly among whom CAD is more common. 4, 12, 21, 22 Cardiogoniometry is a simplified vectorcardiographic method focusing on the angle between the maximal QRS and T vectors, as well as the spatial orientation of these vectors which are very constant in healthy individuals. [9] [10] [11] Deviations of these vectors and angles result from impaired repolarisation of cardiomyocytes due to cardiac pathology, for instance, in case of CAD. [11] [12] [13] [14] Therefore, CGM functions on the cellular level mechanisms which are not very well understood. However, similar and well-known examples of mentioned mechanisms are the following: T-wave memory after tachyarrhythmia or cardiac pacing, 23, 24 the transient or persistent mechanical asynergies in acute or chronic myocardial ischemia and hibernating myocardium 25, 26 as well as diastolic dysfunction detected in echocardiography with regression after complete myocardial reperfusion. 26 In this study only hypokinesia was associated with presence of CAD, which is expected, unlike diastolic dysfunction bearing in mind that the result could be different if the number of patients was higher. Taking this into consideration it is possible that we can detect more electrical phenomena at rest related to latent myocardial ischemia that it is the case today and thus eliminate the belief that electrocardiographic methods have to be combined with stress to detect latent chronic myocardial ischemia. Furthermore, the hypokinesia in echocardiography finding contributes to the efficiency of CGM, which is in line with the fact that latent ischemia can be detected without stress. [23] [24] [25] [26] Based on our findings, CGM could be used as a complementary tool to the exercise-ECG test or even other non-invasive tests currently recommended by the guidelines to discriminate women with CAD (Tables 2 and 3) . It is important to stress that CGM does not entail, as it is the case with some other non-invasive methods, X-ray radiation exposure, which is very important for women, since the chest is the focus of X-ray radiation exposure and breast cancer is the most common tumour in woman, as well as the use of contrast or physical activity related complications. Since it is carried out without stress and easy to provide (only 5 electrodes and lasting 12 s), it is suitable for use in the primary settings.
The results of the present study should be interpreted in the light of certain limitations. This is a single-centre experience performed on a relatively small group of female patients. But the number of patients is as twice as big as the required by power-test (n ¼ 63) and the study was carried out in the University Hospital Centre covering a population of almost half a million people, of whom half are women. However, there may be a referral bias as all female patients were sent to a tertiary medical centre for invasive cardiac assessment. Consequently, it is necessary to carry out further studies including randomization and covering larger number of patients.
In conclusion, CGM is a non-invasive, easy-to-use and free of risk method which showed high effectiveness in diagnosing stable CAD in women and superior to exercise-ECG test for identification of women with functional myocardial ischemia. Consequently, CGM could be introduced as a part of the diagnostic algorithm of screening women for stable CAD. Moreover, given its providing simplicity as well as no need for an expert reader, CGM is suitable for use in the primary settings, especially in women unable to undergo stress testing.
